Science Explorer Back to mapMap
Discussion
Institution · Finch Therapeutics (United States)

Most cited papers from Finch Therapeutics (United States)

Finch Therapeutics (United States)

What are the most cited papers from Finch Therapeutics (United States)?

The most cited paper from Finch Therapeutics (United States) is "Strain Tracking Reveals the Determinants of Bacterial Engraftment in the Human Gut Following Fecal Microbiota Transplantation" (Christopher S. Smillie, Jenny S. Sauk, Dirk Gevers et al., 2018), with 446 citations. Next come "A library of human gut bacterial isolates paired with longitudinal multiomics data enables mechanistic microbiome research" (435) and "Effects of Fecal Microbiota Transplantation With Oral Capsules in Obese Patients" (319).

Showing 50 of 62 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Strain Tracking Reveals the Determinants of Bacterial Engraftment in the Human Gut Following Fecal Microbiota Transplantation Christopher S. Smillie, Jenny S. Sauk, Dirk Gevers et al. · Cell Host & Microbe Open access Feb 2018 446
2 A library of human gut bacterial isolates paired with longitudinal multiomics data enables mechanistic microbiome research Mathilde Poyet et al. · Nature Medicine Sep 2019 435
3 Effects of Fecal Microbiota Transplantation With Oral Capsules in Obese Patients Jessica R. Allegretti, Zain Kassam, Benjamin Harvey Mullish et al. · Clinical Gastroenterology and Hepatology Open access 10 Jul 2019 319
4 Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: A Pilot Clinical Trial Jessica R. Allegretti, Zain Kassam, Madeline Carrellas et al. · The American Journal of Gastroenterology 31 Jan 2019 233
5 Long-term Outcomes of Fecal Microbiota Transplantation in Patients With Cirrhosis Jasmohan Singh Bajaj, Andrew Fagan, Edith A. Gavis et al. · Gastroenterology Open access 18 Jan 2019 181
6 Transferable Immunoglobulin A–Coated Odoribacter splanchnicus in Responders to Fecal Microbiota Transplantation for Ulcerative Colitis Limits Colonic Inflammation Svetlana Ferreira Lima, Lasha Gogokhia, Monica Viladomiu et al. · Gastroenterology Open access 2 Oct 2021 164
7 A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group Josbert J. Keller et al. · United European Gastroenterology Journal Open access 6 Nov 2020 162
8 Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial Olga C. Aroniadis, Lawrence J. Brandt, Caterina Oneto et al. · ˜The œLancet. Gastroenterology & hepatology 17 Jul 2019 159
9 Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic Gianluca Ianiro et al. · Gut Open access 3 Jul 2020 150
10 Distinct Fecal and Plasma Metabolites in Children with Autism Spectrum Disorders and Their Modulation after Microbiota Transfer Therapy Dae‐Wook Kang, James B. Adams, Troy Vargason et al. · mSphere Open access 20 Oct 2020 149
11 Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel Gianluca Ianiro, Benjamin Harvey Mullish, Colleen R. Kelly et al. · ˜The œLancet. Gastroenterology & hepatology Open access 17 Mar 2020 132
12 Donor Screening for Fecal Microbiota Transplantation Zain Kassam, Nancy E. Dubois, Bharat Ramakrishna et al. · New England Journal of Medicine 30 Oct 2019 130
13 Daily, oral FMT for long-term maintenance therapy in ulcerative colitis: results of a single-center, prospective, randomized pilot study Jessica Wood Crothers et al. · BMC Gastroenterology Open access 8 Jul 2021 126
14 Effect of antibiotic pretreatment on bacterial engraftment after Fecal Microbiota Transplant (FMT) in IBS-D Prashant Singh, Eric J. Alm, John M. Kelley et al. · Gut Microbes Open access 11 Jan 2022 121
15 Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis Vinita Elizabeth Jacob, Carl V. Crawford, Shirley Cohen‐Mekelburg et al. · Inflammatory Bowel Diseases Open access 26 Apr 2017 114
16 Introducing the Microbes and Social Equity Working Group: Considering the Microbial Components of Social, Environmental, and Health Justice Suzanne Lynn Ishaq et al. · mSystems Open access 27 Jul 2021 75
17 Combined Endoscopic and Oral Fecal Microbiota Transplantation in Patients with Antibiotic-Dependent Pouchitis: Low Clinical Efficacy due to Low Donor Microbial Engraftment Hans H. Herfarth, Edward Larrabee Barnes, Millie D. Long et al. · Inflammatory Intestinal Diseases Open access 2019 75
18 Fecal Microbiota Transplant Decreases Mortality in Patients with Refractory Severe or Fulminant Clostridioides difficile Infection Yao‐Wen Cheng, Emmalee L. Phelps, Sára Nemes et al. · Clinical Gastroenterology and Hepatology Open access 8 Jan 2020 68
19 Fecal Microbiota Transplantation Capsules with Targeted Colonic Versus Gastric Delivery in Recurrent Clostridium difficile Infection: A Comparative Cohort Analysis of High and Lose Dose Jessica R. Allegretti, Monika Fischer, Sashidhar Varma Sagi et al. · Digestive Diseases and Sciences 4 Dec 2018 67
20 Fecal Microbiota Transplantation in Pouchitis: Clinical, Endoscopic, Histologic, and Microbiota Results from a Pilot Study Daniel Selvig, Yvette M. Piceno, Jonathan P. Terdiman et al. · Digestive Diseases and Sciences 13 Jul 2019 55
21 Staphylococcus epidermidis clones express Staphylococcus aureus-type wall teichoic acid to shift from a commensal to pathogen lifestyle Xin Du, Jesper Larsen, Min Li et al. · Nature Microbiology 24 May 2021 54
22 Strain-resolved analysis in a randomized trial of antibiotic pretreatment and maintenance dose delivery mode with fecal microbiota transplant for ulcerative colitis Byron J. Smith, Yvette M. Piceno, Martin Zydek et al. · Scientific Reports Open access Apr 2022 53
23 Inflammatory Bowel Disease Outcomes Following Fecal Microbiota Transplantation for Recurrent C. difficile Infection Jessica R. Allegretti et al. · Inflammatory Bowel Diseases Open access 6 Nov 2020 53
24 Dynamic Colonization of Microbes and Their Functions after Fecal Microbiota Transplantation for Inflammatory Bowel Disease Nathaniel D. Chu, Jessica Wood Crothers, Le T. T. Nguyen et al. · mBio Open access 20 Jul 2021 52
25 Scaling Safe Access to Fecal Microbiota Transplantation: Past, Present, and Future Pratik Bhikhubhai Panchal, Shrish Budree, Alex Scheeler et al. · Current Gastroenterology Reports 28 Mar 2018 52
26 Impact of fecal microbiota transplantation with capsules on the prevention of metabolic syndrome among patients with obesity Jessica R. Allegretti, Zain Kassam, Jonathan Hurtado et al. · HORMONES Open access 9 Jan 2021 44
27 Outcomes of Fecal Microbiota Transplantation in Patients With Inflammatory Bowel Diseases and Recurrent Clostridioides difficile Infection Jessica R. Allegretti, Colleen R. Kelly, Ari M. Grinspan et al. · Gastroenterology Open access 29 Jul 2020 44
28 Effectiveness and Safety of Fecal Microbiota Transplantation for Clostridioides Difficile Infection: Results From a 5344-Patient Cohort Study Majdi Osman et al. · Gastroenterology Open access 7 Apr 2022 42
29 Exploration of immunoglobulin transcriptomes from mice immunized with three-finger toxins and phospholipases A 2 from the Central American coral snake, Micrurus nigrocinctus Andreas H. Laustsen, Mikael Engmark, Christopher R. Clouser et al. · PeerJ Open access 24 Jan 2017 42
30 Interplay of broccoli/broccoli sprout bioactives with gut microbiota in reducing inflammation in inflammatory bowel diseases Johanna M. Holman, Molly Hurd, Peter L. Moses et al. · The Journal of Nutritional Biochemistry Open access 25 Nov 2022 39
31 PTG-100, an Oral α4β7 Antagonist Peptide: Preclinical Development and Phase 1 and 2a Studies in Ulcerative Colitis William J. Sandborn, Larry C. Mattheakis, Nishit B. Modi et al. · Gastroenterology Open access 30 Aug 2021 37
32 Association of a Remote Patient Monitoring (RPM) Program With Reduced Hospitalizations in Cancer Patients With COVID-19 Joshua C. Pritchett, Bijan J. Borah, Aakash P. Desai et al. · JCO Oncology Practice Open access 4 Jun 2021 35
33 Microbial approaches for targeting antibiotic‐resistant bacteria Wing Fei Wong, Marina Santiago · Microbial Biotechnology Open access 3 Aug 2017 33
34 Risk of Clostridium difficile Infection with Systemic Antimicrobial Therapy Following Successful Fecal Microbiota Transplant: Should We Recommend Anti-Clostridium difficile Antibiotic Prophylaxis? Jessica R. Allegretti, Dina H. Kao, Emmalee L. Phelps et al. · Digestive Diseases and Sciences 10 Jan 2019 30
35 Re-Evaluating the Evidence for Faecal Microbiota Transplantation ‘Super-Donors’ in Inflammatory Bowel Disease Scott W. Olesen, Ylaine Gerardin · Journal of Crohn s and Colitis 12 Aug 2020 28
36 Risk Factors that Predict the Failure of Multiple Fecal Microbiota Transplantations for Clostridioides difficile Infection Jessica R. Allegretti, Shama R. Mehta, Zain Kassam et al. · Digestive Diseases and Sciences 13 Mar 2020 28
37 Stool processing speed and storage duration do not impact the clinical effectiveness of fecal microbiota transplantation Jessica R. Allegretti, Ryan J. Elliott, Alim M. Ladha et al. · Gut Microbes Open access 18 Jun 2020 27
38 Donor Screening for Fecal Microbiota Transplantation in China: Evaluation of 8483 Candidates Shaoyi Zhang, Qiyi Chen, Colleen R. Kelly et al. · Gastroenterology Open access 6 Nov 2021 26
39 Safety and Tolerability of CP101, a Full-Spectrum, Oral Microbiome Therapeutic for the Prevention of Recurrent Clostridioides difficile Infection: A Phase 2 Randomized Controlled Trial Jessica R. Allegretti et al. · Gastroenterology Open access 2 Oct 2024 20
40 Capsule-Delivered Fecal Microbiota Transplant Is Safe and Well Tolerated in Patients with Ulcerative Colitis Elizabeth M. Adler, Adam Tabaa, Zain Kassam et al. · Digestive Diseases and Sciences 27 Mar 2019 19
41 Beyond Fecal Microbiota Transplantation: Developing Drugs from the Microbiome Ylaine Gerardin, Sonia C. Timberlake, Jessica R. Allegretti et al. · The Journal of Infectious Diseases Open access 7 Nov 2020 18
42 Microbiome predictors of dysbiosis and VRE decolonization in patients with recurrent C. difficile infections in a multi-center retrospective study Marina Santiago, 1 Finch Therapeutics, 200 Inner Belt Rd, Somerville, MA 02143, USA, Lindsay M. Eysenbach et al. · AIMS Microbiology Open access 2019 18
43 Fecal Microbiota Transplantation Is Safe for Clostridiodies difficile Infection in Patients with Solid Tumors Undergoing Chemotherapy Robin B. Mendelsohn, Anna Kaltsas, Stephanie J. King et al. · Digestive Diseases and Sciences Open access 4 Jun 2021 17
44 Risk Factors for Gastrointestinal Symptoms Following Successful Eradication of Clostridium difficile by Fecal Microbiota Transplantation (FMT) Jessica R. Allegretti, Zain Kassam, Monika Fischer et al. · Journal of Clinical Gastroenterology 25 Mar 2019 17
45 Steamed broccoli sprouts alleviate DSS-induced inflammation and retain gut microbial biogeography in mice Johanna M. Holman, Louisa Colucci, Dorien Baudewyns et al. · mSystems Open access 13 Sep 2023 16
46 Early life exposure to broccoli sprouts confers stronger protection against enterocolitis development in an immunological mouse model of inflammatory bowel disease Lola E. Holcomb, Johanna M. Holman, Molly Hurd et al. · mSystems Open access 9 Nov 2023 14
47 Using Dialogues to Explore Genetics, Ancestry, and Race Jonathan R. Beckwith, Kostia Bergman, Michael J. Carson et al. · The American Biology Teacher Sep 2017 13
48 Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: The Next Steps in This Promising Story Jessica R. Allegretti, Zain Kassam · The American Journal of Gastroenterology 10 Jul 2019 12
49 Depletion of key gut bacteria predicts disrupted bile acid metabolism in inflammatory bowel disease Daniel A. Peterson, Christopher Weidenmaier, Sonia C. Timberlake et al. · Microbiology Spectrum Open access 13 Dec 2024 8
50 Cost‐effectiveness analysis of sequential fecal microbiota transplantation for fulminant Clostridioides difficile infection Sanchit Gupta, Jinyi Zhu, Thomas R. McCarty et al. · Journal of Gastroenterology and Hepatology 8 Mar 2021 8

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.